Identification of Lenvima:
No description |
Search images on Google Product Monograph
Active Ingredients:
- lenvatinib (lenvatinib mesylate), 18 MG/DOSE
DIN: 02468239
Dosage Form(s): CAPSULE
Route(s) of Administration: ORAL
Description: EACH 18 MG DAILY DOSE CONTAINS 1 X 10 MG & 2 X 4 MG CAPSULES PER BLISTER
Schedule: Prescription
Company: EISAI LIMITED
ATC:
- L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
- L01E - (ATC, WHO)
- L01EX - (ATC, WHO)
- L01EX08 - LENVATINIB (WHO)
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 60X4MG & 30X10MG
Pharmaceutical standard: MFR